Khorsandi, D.Jenson, S.Zarepour, A.Khosravi, A.Rabiee, N.Iravani, S.Zarrabi A.2024-05-192024-05-1920240141-8130https://doi.org/10.1016/j.ijbiomac.2024.131829https://hdl.handle.net/20.500.12713/4252Nanocelluloses exhibit immense potential in catalytic and biomedical applications. Their unique properties, biocompatibility, and versatility make them valuable in various industries, contributing to advancements in environmental sustainability, catalysis, energy conversion, drug delivery, tissue engineering, biosensing/imaging, and wound healing/dressings. Nanocellulose-based catalysts can efficiently remove pollutants from contaminated environments, contributing to sustainable and cleaner ecosystems. These materials can also be utilized as drug carriers, enabling targeted and controlled drug release. Their high surface area allows for efficient loading of therapeutic agents, while their biodegradability ensures safer and gradual release within the body. These targeted drug delivery systems enhance the efficacy of treatments and minimizes side effects. Moreover, nanocelluloses can serve as scaffolds in tissue engineering due to their structural integrity and biocompatibility. They provide a three-dimensional framework for cell growth and tissue regeneration, promoting the development of functional and biologically relevant tissues. Nanocellulose-based dressings have shown great promise in wound healing and dressings. Their ability to absorb exudates, maintain a moist environment, and promote cell proliferation and migration accelerates the wound healing process. Herein, the recent advancements pertaining to the catalytic and biomedical applications of nanocelluloses and their composites are deliberated, focusing on important challenges, advantages, limitations, and future prospects. © 2024 The Authorseninfo:eu-repo/semantics/openAccessBiomedicineCatalytic ApplicationsNanocelluloseCatalytic and biomedical applications of nanocelluloses: A review of recent developmentsReview Article268386776702-s2.0-8519145452610.1016/j.ijbiomac.2024.131829Q1